Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCSL.L Regulatory News (CCSL)

  • There is currently no data for CCSL

Brexit Impact

28 Jun 2016 12:30

RNS Number : 4981C
Chenavari Capital Solutions Limited
28 June 2016
 

28 June 2016

Chenavari Capital Solutions Limited (the "Company")

Brexit Impact on Chenavari Capital Solutions Limited

Market Commentary

Last week, the United Kingdom voted in a referendum to leave the European Union. Significant uncertainties exist on the exit process and the consequences of such decision.

Since this decision, markets have been characterized by extreme volatility in forex and equity, and credit markets are significantly down.

Portfolio Outlook

While we do not expect immediate, direct consequences on the underlying credits in the portfolio, two positions stand out as being highly correlated to the performance of the UK economy:

· A secondary investment in a second loss regulatory capital transaction backed by UK residential mortgages: this transaction has de-levered significantly as it is referencing a static pool of loans. Credit losses continue to be minimal with cumulative losses over 3.2 years at 15.2bps against a second loss representing a 2.19% to 9.87% tranche. While higher unemployment and lower house prices would result in an increase in defaults and losses, the transaction has significant cushion over our base case scenario. This investment represents 5.8% of the Company's NAV as of May month-end.

· A primary investment in a first loss regulatory capital transaction issued by a UK clearing bank referencing large UK corporate borrowers. The transaction is a 0% to 9.6% tranche on a portfolio of £1.86 bn. The underlying corporate borrowers are primarily large UK companies which might be significantly affected by a recession in the UK. No credit event had been recorded in the portfolio as of the March report. This investment represents approximately 11.1% of the Company's NAV as of May month-end.

Impact on the Company

Beyond the two transactions discussed above, the Company's return and NAV might be affected by:

· Marks - We expect a number of capital relief transactions month-end marks to be significantly adversely affected by the extreme volatility and current widening in credit spreads. Approximately 59.7% of the Company's assets are valued on the basis of a dealer valuation and we believe this will result in a reduction in the Company's NAV but it is not possible to estimate the extent of this.

· Hedges and cash collateral - The Company's assets are primarily denominated in currencies other than Sterling. The Company owns assets denominated in Euros, US Dollars and Swiss Francs (together 65.3% of NAV as of May month-end), while the shares were issued in Sterling. Hence, the Company has entered into foreign exchange short-dated swaps to hedge the currency risk.

As of 24 June, the Company held £13m of unencumbered cash, which is available to meet any margin call requirements on its hedges.

Enquiries:

 

Kirstie McLaren

Chenavari Investment Managers

Email: ccslir@chenavari.com

Telephone: +44 20 7259 3600

 

Robert Peel

Fidante Capital

Telephone: +44 20 7832 0900

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFPMMTMBITBMF
Date   Source Headline
20th Apr 20163:30 pmRNSFactsheet Available - March 2016
12th Apr 201611:00 amRNSNet Asset Value(s)
23rd Mar 20165:00 pmRNSFactsheet Available - February 2016
16th Mar 20164:45 pmRNSResult of AGM
16th Mar 201610:00 amRNSNet Asset Value(s)
24th Feb 201612:00 pmRNSFactsheet Available - January 2016
19th Feb 20163:45 pmRNSNet Asset Value(s)
29th Jan 20165:45 pmRNSNotice of AGM
22nd Jan 20163:45 pmRNSDividend Declaration
22nd Jan 20161:00 pmRNSFactsheet Available - December 2015
18th Jan 201610:00 amRNSNet Asset Value(s)
14th Jan 20167:00 amRNSAnnual Financial Report
6th Jan 20167:00 amRNSPrimary Investment
23rd Dec 20157:00 amRNSDirector/PDMR Shareholding
23rd Dec 20157:00 amRNSDirector/PDMR Shareholding
23rd Dec 20157:00 amRNSDirector/PDMR Shareholding
22nd Dec 20155:45 pmRNSFactsheet Available - November 2015
21st Dec 20154:15 pmRNSCompliance with Listing Rule 15.5.1 (4)
18th Dec 20155:00 pmRNSResult of EGM
17th Dec 201511:45 amRNSNet Asset Value(s)
24th Nov 20157:00 amRNSExtension of Investment Period
24th Nov 20157:00 amRNSFactsheet Available - October 2015
23rd Nov 20151:00 pmRNSNet Asset Value(s)
23rd Oct 20155:15 pmRNSFactsheet Available - September 2015
23rd Oct 20154:00 pmRNSAppointment of Chairman
22nd Oct 201512:40 pmRNSDividend Declaration
22nd Oct 201511:00 amRNSNet Asset Value(s)
28th Sep 20152:30 pmRNSPrimary Investment
23rd Sep 201510:00 amRNSFact Sheet Available
18th Sep 20155:30 pmRNSNet Asset Value(s)
24th Aug 20156:01 pmRNSFact sheet available - July 2015
18th Aug 20151:00 pmRNSNet Asset Value(s)
30th Jul 201511:27 amRNSFact sheet available
22nd Jul 20157:00 amRNSDirectorate Change
22nd Jul 20157:00 amRNSDividend Declaration
21st Jul 20158:28 amRNSNet Asset Value(s)
26th Jun 20157:00 amRNSPrimary Investment
24th Jun 201510:30 amRNSNet Asset Value(s)
28th May 201512:00 pmRNSHalf Yearly Report
27th May 20157:00 amRNSNet Asset Value(s)
27th May 20157:00 amRNSDividend Policy and Target Returns
6th May 20155:52 pmRNSPrimary Investment
5th May 20155:00 pmRNSNotification re Director
30th Apr 20154:40 pmRNSNet Asset Value(s)
21st Apr 20153:05 pmRNSDividend Declaration
20th Mar 20153:00 pmRNSNet Asset Value(s)
13th Mar 201512:00 pmRNSResult of AGM
12th Mar 20154:00 pmRNSStatement re Primary Transaction
25th Feb 20159:45 amRNSNet Asset Value(s)
19th Feb 201511:30 amRNSStatement re Primary Transaction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.